Breaking News on Pharmaceutical Technology

Latest news headlines

Products

Suppliers

Pfizer plans to double drug production outsourcing

02-Feb-2007 - Pfizer's latest cutbacks will provide a new outsourcing opportunity for contract manufacturing organisations (CMOs) in low-cost destinations as the drug giant announces plans to double its amount of drug production outsourcing.

Dalton moves into commercial manufacturing services

01-Feb-2007 - Canada's Dalton Pharma Services has been given the green light to start offering commercial sterile manufacturing services to its pharma customers.

Contract manufacturing news in brief

31-Jan-2007 - Hospira, Laureate Pharma, QSV Biologics and Cook Pharmacia all bagged new contract manufacturing deals this week.

Adderall drives pharma division at Johnson Matthey

30-Jan-2007 - Johnson Matthey has announced a reassuring business update ahead of its 31 March year-end, suggesting that Adderall is the driving force behind a recovery in its pharmaceutical materials business.

Lentigen enters disposables market to cut production time

30-Jan-2007 - Viral vector manufacturer Lentigen has entered into a collaboration with Wave Biotech to gain access to disposable process and equipment expertise, which ties in with a shift in the bioprocess manufacturing sector towards using disposable systems.

Xcellerex receives $20m boost for disposable manufacturing tech

30-Jan-2007 - US-based firm Xcellerex yesterday announced it has completed the second half of a $20m (€15.4m) financing deal, raising $11m to speed up commercialisation of its innovative disposable manufacturing technology for vaccines and biotherapeutics.

Verona Pharma picks UK firm for outsourcing

30-Jan-2007 - UK biotech company Verona Pharma has contracted fellow UK firm Onyx to manufacture supplies of its new hay fever drug candidate for forthcoming preclinical and clinical studies.

Lonza scores 18 per cent net profit on biopharma strategy

25-Jan-2007 - Swiss chemicals firm and contract manufacturer Lonza has announced 18 per cent rise in net profit in 2006 rising to CHF 222m (€137.4), fuelled by its strategic move into biopharmaceuticals.

Vetter gets green light for new manufacturing plant

25-Jan-2007 - Germany's Vetter Pharma-Fertigung has announced it has obtained a manufacturing license for its new facility which will expand its services by adding vial filling for lyophilised (freeze-dried) products to its portfolio, in addition to dual-chamber syringes and cartridges filling.

QSV inks two clinical trial manufacturing contracts

24-Jan-2007 - Canadian contract manufacturer QSV Biologics has signed two manufacturing deals in as many weeks, strengthening its position in the Phase II and III clinical supplies arena.

Saltigo gets €40m investment boost from Lanxess

23-Jan-2007 - German fine chemicals company Saltigo is benefiting from a cash injection from its parent company, Lanxess. The German firm is earmarking €30m for plant modernisation at its subsidiary, and a €10m brand new multi-purpose facility is already under construction.

Workhorse analytical tools to reduce human errors

22-Jan-2007 - Agilent Technologies has signed an agreement with Groton Biosystems to co-market measuring solutions for the pharmaceutical industry, as the Process Analytical Technology (PAT) initiative gains popularity among drug manufacturers constantly looking for ways to improve processing efficiencies and costs.

Tocris Bioscience completes $40m management buy out

17-Jan-2007 - Tocris, a leading supplier of chemicals, peptides and antibodies to the major pharmaceutical companies, universities and research institutes has completed a $40m (€30.8m) management buy out (MBO) from its founders.

Small Eno River Labs thinks big

16-Jan-2007 - The booming pharmaceutical contract research market sees a new player enter the arena as analytical lab Eno River Labs separates into two independent divisions to create a new business that will provide analytical and formulation services to the pharmaceutical industry.

Biopharma facing 2007 talent tug-of war

10-Jan-2007 - 2007 will be a tough year for pharmaceutical employers as the industry struggles to find enough staff with specialised technical skills and industry experience, says new research.

Helix picks BioVectra to manufacture new lung cancer bulk drug

10-Jan-2007 - Helix BioPharma and BioVectra have signed a deal for the manufacture of Helix's new lung cancer drug for clinical trials - a move that strengthens the already existing relationship between the two Canadian firms.

India's drug makers set for business influx

09-Jan-2007 - India's drug manufacturing industry is tipped to grow 10 per cent over the next three years as more pharma firms shift operations there to cut costs, says a research report.

Melbourn Scientific expands parenteral testing capacity

08-Jan-2007 - Melbourn Scientific has invested in a light obscuration particle counter to size and count particles in liquid samples using light microscopy, to expand the company's capacity in stability testing and to increase throughput and efficiency.

Amgen evolve Galapagos collaboration

04-Jan-2007 - Galapagos will continue to feed Amgen's drug discovery programmes having expanded the long-standing partnership between the two companies.

Almac Pharma completes formulation plant expansion

04-Jan-2007 - Solid oral dose product specialist Almac Pharma has announced it has expanded its formulation facilities located at its UK headquarters to provide a wider range of services to pharma and biotech companies.

Dishman Pharma has its eyes set on biotech CRO companies

03-Jan-2007 - India's Dishman Pharmaceuticals & Chemicals is planning to snap up biotech and nanotech contract research organisation (CRO) companies in Europe and in the US within drug conjugates to expand their biologics capability.

Pfizer increases Genotropin manufacturing capacity in Sweden

02-Jan-2007 - Pfizer has entered a capacity expansion phase, to meet requirements of global manufacturing of Genotropin (somatropin), a top-selling human growth hormone.

NNE scoops up Fresenius' Pharmaplan

20-Dec-2006 - NNE and Fresenius ProServe yesterday announced they had reached an agreement by which NNE will acquire Fresenius' subsidiary, engineering company Pharmaplan GmbH.

Wyeth kicks off CMO agreement with Crucell

20-Dec-2006 - Crucell yesterday announced it had received the first orders from US-headquartered Wyeth Biotech. The order represents the first move following the finalisation of the contract manufacturing agreement between the two companies at the end of 2005.

GSK sign world's-biggest licensing deal with Genmab

20-Dec-2006 - GlaxoSmithKline (GSK) has broken an industry record by licensing a drug for leukaemia from Genmab for $2.1bn (€1.6bn).

Sign up for your free newsletter